Research

Infectious diseases and microbiome

Search publications

Publications

  • Sánchez-Manubens J, Henares-Bonilla D, Munoz-Almagro C, Brotons-de los Reyes P, Timoneda-Sole N and Anton-Lopez J.

    Characterization of the nasopharyngeal microbiome in patients with Kawasaki disease

    anales de pediatria . 97(5): 300-309. Number of citations: 2

    [doi:10.1016/j.anpedi.2021.11.010]

  • Santos Bravo M, Plault N, Sánchez-Palomino S, Rodríguez C, Navarro Gabriel M, Mosquera MM, Fernández Avilés F, Suarez-Lledó M, Rovira M, Bodro M, Moreno A, Linares L, Cofan F, Berengua C, Esteva-Afonso C, Cordero E, Martin-Davila P, Aranzamendi M, Pérez Jiménez AB, Vidal E, Fernández Sabé N, Len O, Hantz S, Alain S and Marcos MÁ.

    Genotypic and Phenotypic Study of Antiviral Resistance Mutations in Refractory Cytomegalovirus Infection

    JOURNAL OF INFECTIOUS DISEASES . 226(9): 1528-1536. Number of citations: 6

    [doi:10.1093/infdis/jiac349]

  • Merdrignac L, Acosta L, Habington A, Garcìa Cenoz M, Pandolfi E, Fabiánová K, Jordán-García I, O'Sullivan N, Navasués A, Tozzi AE, Zavadilová J, Jané M, Cotter S, Pitillas NI, Rizzo C, Krížová P, Hanslik T, Munoz-Almagro C, Pastore L, Bacci S, Moren A and Valenciano M.

    Effectiveness of pertussis vaccination in pregnancy to prevent hospitalisation in infants aged <2 months and effectiveness of both primary vaccination and mother?s vaccination in pregnancy in infants aged 2-11 months

    Vaccine . 40(44): 6374-6382. Number of citations: 23

    [doi:10.1016/j.vaccine.2022.09.054]

  • Goncé A, Hawkins-Villarreal A, Salazar L, Guirado L, Marcos MA, Pascual Mancho J, Prats P, López M, Eixarch E, Salvia MD, Fortuny-Guasch C and Figueras-Retuerta F.

    Maternal high-dose valacyclovir and its correlation with newborn blood viral load and outcome in congenital cytomegalovirus infection

    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE . 35(20): 4004-4008. Number of citations: 7

    [doi:10.1080/14767058.2020.1843016]

  • Lo SW, Mellor K, Cohen R, Redin-Alonso A, Belman S, Kumar N, Hawkins PA, Gladstone RA, von Gottberg A, Veeraraghavan B, Ravikumar KL, Kandasamy R, Pollard SAJ, Saha SK, Bigogo G, Antonio M, Kwambana-Adams B, Mirza S, Shakoor S, Nisar I, Cornick JE, Lehmann D, Ford RL, Sigauque B, Turner P, Moïsi J, Obaro SK, Dagan R, Diawara I, Skoczynska A, Wang H, Carter PE, Klugman KP, Rodgers G, Breiman RF, McGee L, Bentley SD, Munoz-Almagro C and Varon E.

    Emergence of a multidrug-resistant and virulent Streptococcus pneumoniae lineage mediates serotype replacement after PCV13: an international whole-genome sequencing study

    Lancet Microbe . 3(10): 735-743. Number of citations: 49

    [doi:10.1016/S2666-5247(22)00158-6]

  • Aguilera-Alonso, D, Solis-Garcia, G, Noguera-Julian A, Gonzalez-Martin, J, Cobena, AR, Baquero-Artigao, F, Rueda, CT, Rodriguez-Molino, P, Sanchez, IB, Vallmanya, T, Bernet-Sanchez, A, Domingo, LM, Rubio, A, Saavedra-Lozano, J, Ruiz-Serrano, MJ, Blazquez-Gamero, D, Lopez-Roa, P, Gomez-Pastrana, D, Prieto, MDL, Medina, EML, Gil-Brusola, A, Nalda, AM, Soriano-Arandes, A, Tortola, T, Falcon-Neyra, L, Galan, VG, Tebruegge, M and Santiago-Garcia, B.

    Accuracy of Xpert Ultra for the diagnosis of paediatric tuberculosis in a low TB burden country: a prospective multicentre study

    Thorax . 77(10): 1023-1029. Number of citations: 9

    [doi:10.1136/thorax-2021-218378]

  • Torres-Fernandez D, Jiménez de Ory S, Fortuny-Guasch C, Sainz T, Falcón D, Bernal E, Jiménez MC, Vilasaró MN, Epalza C, Navarro M, Ramos JT, Holguín Á and Prieto L.

    Integrase inhibitors in children and adolescents: clinical use and resistance

    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY . 77(10): 2784-2792. Number of citations: 5

    [doi:10.1093/jac/dkac259]

  • Turkova A, Waalewijn H, Chan MK, Bollen PDJ, Bwakura-Dangarembizi MF, Kekitiinwa AR, Cotton MF, Lugemwa A, Variava E, Ahimbisibwe GM, Srirompotong U, Mumbiro V, Amuge P, Zuidewind P, Ali S, Kityo CM, Archary M, Ferrand RA, Violari A, Gibb DM, Burger DM, Ford D and Colbers A.

    Dolutegravir twice-daily dosing in children with HIV-associated tuberculosis: a pharmacokinetic and safety study within the open-label, multicentre, randomised, non-inferiority ODYSSEY trial

    Lancet HIV . 9(9): 627-637. Number of citations: 21

    [doi:10.1016/S2352-3018(22)00160-6]

  • Amuge P, Lugemwa A, Wynne B, Mujuru HA, Violari A, Kityo CM, Archary M, Variava E, White E, Turner RM, Shakeshaft C, Ali S, Nathoo KJ, Atwine L, Liberty A, Bbuye D, Kaudha E, Mngqibisa R, Mosala M, Mumbiro V, Nanduudu A, Ankunda R, Maseko L, Kekitiinwa AR, Giaquinto C, Rojo P, Gibb DM, Turkova A and Ford D.

    Once-daily dolutegravir-based antiretroviral therapy in infants and children living with HIV from age 4 weeks: results from the below 14 kg cohort in the randomised ODYSSEY trial

    Lancet HIV . 9(9): 638-648. Number of citations: 23

    [doi:10.1016/S2352-3018(22)00163-1]

  • Armero-Campos G, Penela-Sánchez D, Belmonte J, Gómez-Barroso D, Larrauri A, Henares-Bonilla D, Violeta Vallejo Matavera, Jordán-García I, Munoz-Almagro C, Brotons-de los Reyes P and Launes-Montana C.

    Concentrations of nitrogen compounds are related to severe rhinovirus infection in infants. A time-series analysis from the reference area of a pediatric university hospital in Barcelona

    PEDIATRIC PULMONOLOGY . 57(9): 2180-2188. Number of citations: 2

    [doi:10.1002/ppul.26021]